These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 27517370)

  • 21. Quantitative Apparent Diffusion Coefficients From Peritumoral Regions as Early Predictors of Response to Neoadjuvant Systemic Therapy in Triple-Negative Breast Cancer.
    Musall BC; Adrada BE; Candelaria RP; Mohamed RMM; Abdelhafez AH; Son JB; Sun J; Santiago L; Whitman GJ; Moseley TW; Scoggins ME; Mahmoud HS; White JB; Hwang KP; Elshafeey NA; Boge M; Zhang S; Litton JK; Valero V; Tripathy D; Thompson AM; Yam C; Wei P; Moulder SL; Pagel MD; Yang WT; Ma J; Rauch GM
    J Magn Reson Imaging; 2022 Dec; 56(6):1901-1909. PubMed ID: 35499264
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The Effectiveness of Volumetric MRI Histogram Analysis in Renal Cell Carcinoma.
    Akıncı Ö; Türkoglu F; Nalbant MO; Öner Ö; İnci E
    Acad Radiol; 2023 Sep; 30 Suppl 1():S278-S285. PubMed ID: 37105802
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Changes in Apparent Diffusion Coefficient as Surrogate Marker for Changes in Ki-67 Index Due to Neoadjuvant Chemotherapy in Patients with Invasive Breast Cancer.
    Luo N; Ji Y; Huang X; Liu Y; Liu L; Jin G; Zhao X; Zhu X; Su D
    Acad Radiol; 2019 Oct; 26(10):1352-1357. PubMed ID: 30711409
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Metastatic ovarian and primary peritoneal cancer: assessing chemotherapy response with diffusion-weighted MR imaging--value of histogram analysis of apparent diffusion coefficients.
    Kyriazi S; Collins DJ; Messiou C; Pennert K; Davidson RL; Giles SL; Kaye SB; Desouza NM
    Radiology; 2011 Oct; 261(1):182-92. PubMed ID: 21828186
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Quantitative evaluation of breast cancer response to neoadjuvant chemotherapy by diffusion tensor imaging: Initial results.
    Furman-Haran E; Nissan N; Ricart-Selma V; Martinez-Rubio C; Degani H; Camps-Herrero J
    J Magn Reson Imaging; 2018 Apr; 47(4):1080-1090. PubMed ID: 28901594
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Comparison between borderline ovarian tumors and carcinomas using semi-automated histogram analysis of diffusion-weighted imaging: focusing on solid components.
    Mimura R; Kato F; Tha KK; Kudo K; Konno Y; Oyama-Manabe N; Kato T; Watari H; Sakuragi N; Shirato H
    Jpn J Radiol; 2016 Mar; 34(3):229-37. PubMed ID: 26798066
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Pretreatment apparent diffusion coefficient does not predict therapy response to neoadjuvant chemotherapy in breast cancer.
    Surov A; Wienke A; Meyer HJ
    Breast; 2020 Oct; 53():59-67. PubMed ID: 32652460
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Gliomas: Histogram analysis of apparent diffusion coefficient maps with standard- or high-b-value diffusion-weighted MR imaging--correlation with tumor grade.
    Kang Y; Choi SH; Kim YJ; Kim KG; Sohn CH; Kim JH; Yun TJ; Chang KH
    Radiology; 2011 Dec; 261(3):882-90. PubMed ID: 21969667
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effectiveness of ADC Difference Value on Pre-neoadjuvant Chemotherapy MRI for Response Evaluation of Breast Cancer.
    Choi BB
    Technol Cancer Res Treat; 2021; 20():15330338211039129. PubMed ID: 34519583
    [No Abstract]   [Full Text] [Related]  

  • 30. Diffusion-weighted MRI in pretreatment prediction of response to neoadjuvant chemotherapy in patients with breast cancer.
    Richard R; Thomassin I; Chapellier M; Scemama A; de Cremoux P; Varna M; Giacchetti S; Espié M; de Kerviler E; de Bazelaire C
    Eur Radiol; 2013 Sep; 23(9):2420-31. PubMed ID: 23652844
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Histogram analysis of apparent diffusion coefficient map of diffusion-weighted MRI in endometrial cancer: a preliminary correlation study with histological grade.
    Woo S; Cho JY; Kim SY; Kim SH
    Acta Radiol; 2014 Dec; 55(10):1270-7. PubMed ID: 24316663
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Diffusion-weighted imaging reflects pathological therapeutic response and relapse in breast cancer.
    Fujimoto H; Kazama T; Nagashima T; Sakakibara M; Suzuki TH; Okubo Y; Shiina N; Fujisaki K; Ota S; Miyazaki M
    Breast Cancer; 2014 Nov; 21(6):724-31. PubMed ID: 23400545
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Role of diffusion-weighted imaging as an adjunct to contrast-enhanced breast MRI in evaluating residual breast cancer following neoadjuvant chemotherapy.
    Hahn SY; Ko EY; Han BK; Shin JH; Ko ES
    Eur J Radiol; 2014 Feb; 83(2):283-8. PubMed ID: 24315957
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Histogram analysis of volume-based apparent diffusion coefficient in breast cancer.
    Park GE; Kim SH; Kim EJ; Kang BJ; Park MS
    Acta Radiol; 2017 Nov; 58(11):1294-1302. PubMed ID: 28273747
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Diffusion-weighted magnetic resonance imaging in monitoring rectal cancer response to neoadjuvant chemoradiotherapy.
    Barbaro B; Vitale R; Valentini V; Illuminati S; Vecchio FM; Rizzo G; Gambacorta MA; Coco C; Crucitti A; Persiani R; Sofo L; Bonomo L
    Int J Radiat Oncol Biol Phys; 2012 Jun; 83(2):594-9. PubMed ID: 22099033
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Feasibility of 7 Tesla breast magnetic resonance imaging determination of intrinsic sensitivity and high-resolution magnetic resonance imaging, diffusion-weighted imaging, and (1)H-magnetic resonance spectroscopy of breast cancer patients receiving neoadjuvant therapy.
    Korteweg MA; Veldhuis WB; Visser F; Luijten PR; Mali WP; van Diest PJ; van den Bosch MA; Klomp DJ
    Invest Radiol; 2011 Jun; 46(6):370-6. PubMed ID: 21317792
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Rim sign and histogram analysis of apparent diffusion coefficient values on diffusion-weighted MRI in triple-negative breast cancer: Comparison with ER-positive subtype.
    Choi Y; Kim SH; Youn IK; Kang BJ; Park WC; Lee A
    PLoS One; 2017; 12(5):e0177903. PubMed ID: 28542297
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Diffusion-weighted magnetic resonance imaging for pretreatment prediction and monitoring of treatment response of patients with locally advanced breast cancer undergoing neoadjuvant chemotherapy.
    Nilsen L; Fangberget A; Geier O; Olsen DR; Seierstad T
    Acta Oncol; 2010 Apr; 49(3):354-60. PubMed ID: 20397769
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Assessment of response to chemotherapy in pancreatic ductal adenocarcinoma: Comparison between diffusion-weighted MR quantitative parameters and RECIST.
    Bali MA; Pullini S; Metens T; Absil J; Chao SL; Marechal R; Matos C; Peerboccus BM; Van Laethem JL
    Eur J Radiol; 2018 Jul; 104():49-57. PubMed ID: 29857866
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Diffusion-weighted and dynamic contrast-enhanced MRI in evaluation of early treatment effects during neoadjuvant chemotherapy in breast cancer patients.
    Jensen LR; Garzon B; Heldahl MG; Bathen TF; Lundgren S; Gribbestad IS
    J Magn Reson Imaging; 2011 Nov; 34(5):1099-109. PubMed ID: 22002757
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.